Dalbavancin is a semisynthetic lipoglycopeptide that was designed to improve upon the natural glycopeptides currently available, vancomycin and teicoplanin. It possesses in vitro activity against a variety of Gram-positive pathogens including MRSA and methicillin-resistant Staphylococcus epidermidis (MRSE). For more information, please visit the website: https://www.creative-peptides.com/product/dalbavancin-impurity-item-z10-101-160-34592.html
